Condition: Drug Allergy
Intervention: Drug: Omalizumab
Sponsors: Dana-Farber Cancer Institute; Novartis Pharmaceuticals
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Breathe Well Live Well